Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 millionInvivyd in vitro data showed continued ...
Tom Barrett, who is running for re-election in Michigan’s 7th Congressional District, shared in a wide-ranging interview on ...
Q1 2026 Earnings Call May 13, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results